title: Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?
abstract: The classic model for neurodegeneration due to mutations in DNA repair genes holds that DNA damage accumulates in the absence of repair, resulting in the death of neurons. This model was originally put forth to explain the dramatic loss of neurons observed in patients with xeroderma pigmentosum neurologic disease, and is likely to be valid for other neurodegenerative diseases due to mutations in DNA repair genes. However, in trichiothiodystrophy (TTD), Aicardi-Goutières syndrome (AGS), and Cockayne syndrome (CS), abnormal myelin is the most prominent neuropathological feature. Myelin is synthesized by specific types of glial cells called oligodendrocytes. In this review, we focus on new studies that illustrate two disease mechanisms for myelin defects resulting from mutations in DNA repair genes, both of which are fundamentally different than the classic model described above. First, studies using the TTD mouse model indicate that TFIIH acts as a co-activator for thyroid hormone-dependent gene expression in the brain, and that a causative XPD mutation in TTD results in reduction of this co-activator function and a dysregulation of myelin-related gene expression. Second, in AGS, which is caused by mutations in either TREX1 or RNASEH2, recent evidence indicates that failure to degrade nucleic acids produced during S-phase triggers activation of the innate immune system, resulting in myelin defects and calcification of the brain. Strikingly, both myelin defects and brain calcification are both prominent features of CS neurologic disease. The similar neuropathology in CS and AGS seems unlikely to be due to the loss of a common DNA repair function, and based on the evidence in the literature, we propose that vascular abnormalities may be part of the mechanism that is common to both diseases. In summary, while the classic DNA damage accumulation model is applicable to the neuronal death due to defective DNA repair, the myelination defects and brain calcification seem to be better explained by quite different mechanisms. We discuss the implications of these different disease mechanisms for the rational development of treatments and therapies.
authors.affiliation: Section on Molecular Neurobiology, Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, 5625 Fishers Lane, Room 3S32, Rockville, MD 20852, USA. pjbrooks@mail.nih.gov <pjbrooks@mail.nih.gov>
authors.forename: P J
authors.initials: PJ
authors.lastname: Brooks
authors.forename: Tsu-Fan
authors.initials: TF
authors.lastname: Cheng
authors.forename: Lori
authors.initials: L
authors.lastname: Cooper
mesh_terms: D001927:Brain Diseases / Q000235:genetics* / Q000276:immunology / Q000473:pathology / Q000628:therapy; D004249:DNA Damage; D004260:DNA Repair / Q000235:genetics*; D006801:Humans; D007113:Immunity, Innate; D009154:Mutation; D051758:Transcription Factor TFIIH / Q000378:metabolism
chemical_list: D051758:Transcription Factor TFIIH